Attayeb Mohsen

Dr. Attayeb Mohsen

National Institutes of Biomedical Innovation, Health and Nutrition
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2013 in Glia
Verified
Journal Article
Closed access
PDF file
TYTakeo Yoshikawa
Takeo Yoshikawa
FNFumito Naganuma
Fumito Naganuma
TITomomitsu Iida
Tomomitsu Iida
TNTadaho Nakamura
Tadaho Nakamura
RHRyuichi Harada
Ryuichi Harada
KYKazuhiko Yanai
Kazuhiko Yanai

15 November 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
Attayeb MohsenAttayeb Mohsen
Attayeb Mohsen
JPJonguk Park
Jonguk Park
YCYi-An Chen
Yi-An Chen
HKHitoshi Kawashima
Hitoshi Kawashima
KMKenji Mizuguchi
Kenji Mizuguchi
Background: To increase the accuracy of microbiome data analysis, solving the technical limitations of the existing sequencing machines is required. Quality trimming is suggested to reduce the effect of the progressive decrease in sequencing quality with the increased length of the sequenced library. In this study, we examined the effect of the trimming thresholds (0–20 for QIIME1 and 0–30 for QIIME2) on the number of reads that remained after the quality control and chimera removal (the good reads). We also examined the distance of the analysis results to the gold standard using simulated samples.Results: Quality trimming increased the number of good reads and abundance measurement accuracy in Illumina paired-end reads of the V3-V4 hypervariable region.Conclusions: Our results suggest that the pre-analysis trimming step should be included before the application of QIIME1 or QIIME2.

1 October 2014 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
TYTakeo Yoshikawa
Takeo Yoshikawa
TNTadaho Nakamura
Tadaho Nakamura
TSTetsuro Shibakusa
Tetsuro Shibakusa
MSMayu Sugita
Mayu Sugita
FNFumito Naganuma
Fumito Naganuma
KYKazuhiko Yanai
Kazuhiko Yanai
L-histidine is one of the essential amino acids for humans, and it plays a critical role as a component of proteins. L-histidine is also important as

27 October 2021 in Frontiers in Drug Discovery
Verified
Journal Article
Open access
Attayeb MohsenAttayeb Mohsen
Attayeb Mohsen
LTLokesh P. Tripathi
Lokesh P. Tripathi
KMKenji Mizuguchi
Kenji Mizuguchi
Machine learning techniques are being increasingly used in the analysis of clinical and omics data. This increase is primarily due to the advancements in Artificial intelligence (AI) and the build-up of health-related big data. In this paper we have aimed at estimating the likelihood of adverse drug reactions or events (ADRs) in the course of drug discovery using various machine learning methods. We have also described a novel machine learning-based framework for predicting the likelihood of ADRs. Our framework combines two distinct datasets, drug-induced gene expression profiles from Open TG–GATEs (Toxicogenomics Project–Genomics Assisted Toxicity Evaluation Systems) and ADR occurrence information from FAERS (FDA [Food and Drug Administration] Adverse Events Reporting System) database, and can be applied to many different ADRs. It incorporates data filtering and cleaning as well as feature selection and hyperparameters fine tuning. Using this framework with Deep Neural Networks (DNN), we built a total of 14 predictive models with a mean validation accuracy of 89.4%, indicating that our approach successfully and consistently predicted ADRs for a wide range of drugs. As case studies, we have investigated the performances of our prediction models in the context of Duodenal ulcer and Hepatitis fulminant, highlighting mechanistic insights into those ADRs. We have generated predictive models to help to assess the likelihood of ADRs in testing novel pharmaceutical compounds. We believe that our findings offer a promising approach for ADR prediction and will be useful for researchers in drug discovery.

16 May 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JPJonguk Park
Jonguk Park
KHKoji Hosomi
Koji Hosomi
HKHitoshi Kawashima
Hitoshi Kawashima
YCY. Ann Chen
Y. Ann Chen
Attayeb MohsenAttayeb Mohsen
Attayeb Mohsen
KMKenji Mizuguchi
Kenji Mizuguchi
The gut microbiota is closely related to good health; thus, there have been extensive efforts dedicated to improving health by controlling the gut microbial environment. Probiotics and prebiotics are being developed to support a healthier intestinal environment. However, much work remains to be performed to provide effective solutions to overcome individual differences in the gut microbial community. This study examined the importance of nutrients, other than dietary fiber, on the survival of gut bacteria in high-health-conscious populations. We found that vitamin B1, which is an essential nutrient for humans, had a significant effect on the survival and competition of bacteria in the symbiotic gut microbiota. In particular, sufficient dietary vitamin B1 intake affects the relative abundance of Ruminococcaceae, and these bacteria have proven to require dietary vitamin B1 because they lack the de novo vitamin B1 synthetic pathway. Moreover, we demonstrated that vitamin B1 is involved in the production of butyrate, along with the amount of acetate in the intestinal environment. We established the causality of possible associations and obtained mechanical insight, through in vivo murine experiments and in silico pathway analyses. These findings serve as a reference to support the development of methods to establish optimal intestinal environment conditions for healthy lifestyles.

20 May 2021 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
JPJonguk Park
Jonguk Park
KKKumiko Kato
Kumiko Kato
HMHaruka Murakami
Haruka Murakami
KHKoji Hosomi
Koji Hosomi
KTKumpei Tanisawa
Kumpei Tanisawa
MMMotohiko Miyachi
Motohiko Miyachi
Background: Inter-individual variations in gut microbiota composition are observed even among healthy populations. The gut microbiota may exhibit a unique composition depending on the country of origin and race of individuals. To comprehensively understand the link between healthy gut microbiota and host state, it is beneficial to conduct large-scale cohort studies. The aim of the present study was to elucidate the integrated and non-redundant factors associated with gut microbiota composition within the Japanese population by 16S rRNA sequencing of fecal samples and questionnaire-based covariate analysis. Results: A total of 1596 healthy Japanese individuals participated in this study via two independent cohorts, NIBIOHN cohort (n = 954) and MORINAGA cohort (n = 642). Gut microbiota composition was described and the interaction of these microorganisms with metadata parameters such as anthropometric measurements, bowel habits, medical history, and lifestyle were obtained. Thirteen genera, including Alistipes, Anaerostipes, Bacteroides, Bifidobacterium, Blautia, Eubacterium halli group, Faecalibacterium, Fusicatenibacter, Lachnoclostridium, Parabacteroides, Prevotella_9, Roseburia, and Subdoligranulum were predominant among the two cohorts. On the basis of univariate analysis for overall microbiome variation, 18 matching variables exhibited significant association in both cohorts. A stepwise redundancy analysis revealed that there were four common covariates, Bristol Stool Scale (BSS) scores, gender, age, and defecation frequency, displaying non-redundant association with gut microbial variance. Conclusions: We conducted a comprehensive analysis of gut microbiota in healthy Japanese individuals, based on two independent cohorts, and obtained reliable evidence that questionnaire-based covariates such as frequency of bowel movement and specific dietary habit affects the microbial composition of the gut. To our knowledge, this was the first study to investigate integrated and non-redundant factors associated with gut microbiota among Japanese populations.